自發性震顫市場報告：至2031年的趨勢、預測與競爭分析

全球自發性震顫市場前景光明，醫院、門診手術中心以及診斷和專科診所市場都蘊藏著巨大的機會。預計2025年至2031年，全球自發性震顫市場將以5.3%的年複合成長率成長。該市場的主要驅動力包括自發性震顫的上升、認知度的提高和早期診斷的提升，以及治療方案的增加。

• Lucintel 預測，依適應症，上肢將在預測期內經歷最高的成長。
• 根據最終用途，預計醫院將實現最高成長。
• 根據地區，預計北美將在預測期內實現最高成長。

自發性震顫市場的新趨勢

自發性震顫市場瞬息萬變，許多新興趨勢定義其未來發展方向。這些趨勢表明，市場對更有效的治療方法、更便捷的患者可及性以及有效管理自發性震顫的創新解決方案的需求日益成長。

• 外科治療的技術進步：深部腦部刺激（DBS）和聚焦超音波技術改變自發性震顫的治療。 DBS 的進展改善了患者的益處，並以微創的方式提供長期症狀緩解。聚焦超音波正變得越來越流行，因為它是一種微創技術，無需手術即可針對引起震顫的腦區進行治療。這些技術改善了患者的生活，並有望成為更受歡迎的治療方法。
• 藥物研發：藥物領域的新進展，包括針對震顫症狀的特異性標靶藥物的核准，促進了自發性震顫市場的發展。先前只能透過仿單標示外途徑取得的藥物，如今已可用於處方，改善了特發性震顫患者的症狀控制。近期的治療方法目的是透過提供更具針對性的治療方法來減少副作用並改善患者預後。隨著研究的進展，在特發性震顫背後的機制研究方面可能會取得進一步的突破。
• 重視非侵入性治療：針對自發性震顫的非侵入性治療，例如聚焦超音波治療和經顱磁刺激（TMS），正日益普及。這些治療是傳統外科手術治療（包括深部腦電刺激（DBS））的微創治療方法，並且因其恢復時間更短、併發症更少而廣受歡迎。隨著這些非侵入性治療獲得臨床檢驗，它們很可能在特發性震顫的治療中發揮重要作用。
• 以病人為中心的醫療模式：以病人為中心的醫療模式是自發性震顫市場的關鍵趨勢。此模式著重於個人化治療方案，目的是滿足每位患者的特定需求。透過包括物理治療、諮詢和生活方式調整在內的整體管理，該模式目的是提升患者的整體健康水準。隨著越來越多的人意識到以患者為中心的醫療模式的重要性，預計該模式將改善治療效果並提升患者滿意度。
• 遠距監控與遠端醫療：遠端醫療和遠距監控技術的發展徹底改變自發性震顫的治療。遠端醫療使患者和專家能夠進行遠距會診，改善醫療資源匱乏人群的治療可近性。遠端監控設備還能即時追蹤症狀，使臨床醫師能夠相應地調整治療方案。這些技術有可能提高患者參與度並簡化治療方法，尤其適用於醫療資源有限的弱勢群體。

這些新興趨勢正以更有效、更經濟、更方便患者的治療方法改變自發性震顫市場。科技、藥物和患者照護的進步刺激成長，而非侵入性介入和遠端醫療則改善治療的可及性。隨著這些趨勢的持續，自發性震顫的治療將持續改進，全球患者照護也將提升。

自發性震顫市場的最新趨勢

自發性震顫市場的最新發展表明，人們對成功治療和改善疾病控制的興趣日益濃厚。以下是影響市場的五大主要發展趨勢：

• 新藥核准：新藥的核准為自發性震顫的治療帶來了新的藥物。這些藥物目的是提供更有針對性的症狀緩解，並減少副作用。這些新藥的出現，以及舊藥的不斷發展，改善特發性震顫患者的整體治療前景。
• 外科手術的進展：深部腦部刺激（DBS）在技術和療效方面均取得了顯著進展，為患有嚴重震顫的患者提供了持久的緩解。聚焦超音波等非手術干涉措施也已作為 DBS 的替代方案推出，使患者能夠選擇在不進行手術的情況下治療震顫。
• 放大聚焦超音波和經顱磁刺激（TMS）等非侵入性治療正日益流行，因為它們能夠以比手術更小的創傷性程度減輕震顫。對於不願接受侵入性手術或有手術禁忌症的患者來說，此類治療尤其具有吸引力。
• 遠端醫療的成長機會：遠端醫療已成為自發性震顫市場的重大技術創新，尤其是在新冠疫情期間。遠端醫療使患者能夠遠端聯繫專家，方便居住在偏遠地區的患者接受診斷和治療。遠端醫療平台的擴展預計將持續成為一種經濟實惠且省時的患者管理方案。
• 提高意識和教育宣傳活動：自發性震顫的提高意識和教育舉措促進早期診斷和治療。認知的提高使更多患者在疾病早期接受治療，改善了長期療效。此類宣傳活動也減少偏見，並確保了特發性震顫患者得到適當的治療。

這些進展推動了自發性震顫市場的發展，推動了新治療方法的開發、治療管道的擴展以及人們對該疾病的認知度的提高。隨著市場的成長，這些創新將改善全球自發性震顫患者的治療效果和生活品質。

目錄

第1章 執行摘要

第2章 全球自發性震顫市場：市場動態

• 簡介、背景和分類
• 供應鏈
• 產業驅動力與挑戰

第3章 2019年至2031年市場趨勢及預測分析

• 宏觀經濟趨勢（2019-2024）及預測（2025-2031）
• 全球自發性震顫市場趨勢（2019-2024年）及預測（2025-2031年）
• 依適應症
  • 頭
  • 身體軀幹
  • 上肢
  • 下肢
• 全球自發性震顫市場（依最終用途）
  • 醫院
  • 門診手術中心
  • 診斷和專科診所

第4章 2019年至2031年區域市場趨勢與預測分析

• 依地區
• 北美洲
• 歐洲
• 亞太地區
• 其他地區

第5章 競爭分析

• 產品系列分析
• 運作整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 依適應症
  • 依最終用途
  • 依地區
• 全球自發性震顫市場的新趨勢
• 戰略分析
  • 新產品開發
  • 擴大全球自發性震顫市場容量
  • 全球自發性震顫市場的合併、收購與合資企業
  • 認證和許可

第7章 主要企業簡介

• InSightec's
• Merz Pharma
• Neurocrine Biosciences
• Sage Therapeutics

The future of the global essential tremor market looks promising with opportunities in the hospital, ambulatory surgical center, and diagnostic & specialty clinic markets. The global essential tremor market is expected to grow with a CAGR of 5.3% from 2025 to 2031. The major drivers for this market are the rising prevalence of essential tremor, the growing awareness and early diagnosis, and the increasing availability of treatment options.

• Lucintel forecasts that, within the indication category, upper extremity is expected to witness the highest growth over the forecast period.
• Within the end use category, hospital is expected to witness the highest growth.
• In terms of region, North America is expected to witness the highest growth over the forecast period.

Emerging Trends in the Essential Tremor Market

The essential tremor market is changing fast, with a number of emerging trends defining its future. These trends indicate the increasing need for more effective treatments, enhanced patient access, and the continuous quest for innovative solutions to effectively manage Essential Tremor.

• Technological Advancements in Surgical Treatments: Deep brain stimulation (DBS) and focused ultrasound technologies are transforming the treatment of Essential Tremor. DBS has been advanced to enhance patient benefits with less invasive methods, providing long-term symptom reduction. Focused ultrasound, a minimally invasive technique, is increasing popularity because it can target brain regions responsible for producing tremors without surgery. These technologies are enhancing the lives of patients and will likely increase in popularity as a treatment.
• Pharmaceutical Developments: The market for Essential Tremor is being enhanced by new developments in pharmaceuticals, such as the approval of medicines with specific targets for tremor symptoms. Medicines previously only available off-label are increasingly being prescribed, enhancing symptom control for patients with ET. More recent treatments seek to offer more tailored strategies, decreasing side effects and enhancing outcomes for the patients. With advancing research, there are likely to be additional breakthroughs that address the mechanisms behind ET.
• Greater Emphasis on Non-Invasive Treatments: Non-invasive treatment of Essential Tremor is becoming increasingly popular, including focused ultrasound therapy and transcranial magnetic stimulation (TMS). These treatments provide patients with a less invasive alternative to the conventional surgical treatments, including DBS, and are popular because they have shorter recovery times and fewer complications. As these non-invasive treatments become more clinically validated, they will become important in the management of ET.
• Patient-Centered Care Models: Patient-centered care is a significant trend in the essential tremor market. This model focuses on individualized treatment plans that are customized to suit individual patient requirements. With holistic management, such as physical therapy, counseling, and lifestyle modification, this trend seeks to enhance overall patient well-being. As more people become aware of the significance of patient-centered care, we can expect improved outcomes and patient satisfaction.
• Remote Monitoring and Telemedicine: Growth in telemedicine and remote monitoring is revolutionizing the treatment of Essential Tremor. Telemedicine enables remote consultations between patients and specialists, enhancing the accessibility of care for underserved populations. Remote monitoring devices also facilitate real-time tracking of symptoms, enabling clinicians to modify treatments accordingly. These technologies have the potential to enhance patient engagement and simplify treatment regimens, particularly in underserved populations with limited access to healthcare facilities.

These new trends are transforming the essential tremor market with more efficient, affordable, and patient-friendly treatment methods. Advances in technologies, drugs, and patient care are stimulating growth, and non-invasive interventions and telemedicine are enhancing access. As these trends continue to unfold, treatment for Essential Tremor will become increasingly better, and patient care worldwide is likely to increase.

Recent Developments in the Essential Tremor Market

Current developments in the essential tremor market are an indicator of increasing interest in successful treatments and improved control of the condition. Five key developments influencing the market.

• Approval of New Pharmaceutical Treatments: New drug approvals have brought new pharmacological agents to the treatment of Essential Tremor. These drugs are designed to offer more targeted relief from symptoms with fewer side effects. The presence of these new drugs, along with the continued evolution of older drugs, is improving the overall treatment environment for ET patients.
• Progress in Surgical Interventions: Deep brain stimulation (DBS) has experienced notable technique and effectiveness advancements, delivering permanent relief for those suffering from intense tremors. Also, non-surgical interventions such as focused ultrasound are being introduced as options to DBS, providing patients with the alternative of treating tremors without going under the knife.
• Expansion of Non-Invasive Therapies: Non-invasive treatments such as focused ultrasound and transcranial magnetic stimulation (TMS) are increasing in popularity since they can alleviate tremors with minimal invasiveness, compared to surgery. Such treatments are particularly attractive for patients who would rather not have invasive procedures performed or who possess contraindications to undergoing surgery.
• Growth in Telemedicine Opportunities: Telemedicine has emerged as the major innovation in the essential tremor market, particularly during the COVID-19 pandemic. Telemedicine enables patients to access specialists remotely, thereby providing those residing in remote locations with greater access to diagnosis and treatment. The expansion of telemedicine platforms is anticipated to be sustained as an economical and time-saving option for patient management.
• Increasing Awareness and Educational Campaigns: Greater recognition of Essential Tremor, together with educational initiatives, is promoting early diagnosis and treatment. Greater awareness is increasing the number of patients who present for treatment earlier in the course of their disease, resulting in improved long-term outcomes. Such campaigns are also reducing stigma and ensuring ET patients receive appropriate treatment.

These advances are pushing the essential tremor market ahead by developing new treatments, broadening access to treatment, and creating greater awareness of the disease. As the market grows, these innovations will enhance outcomes and quality of life for patients with Essential Tremor around the world.

Strategic Growth Opportunities in the Essential Tremor Market

The essential tremor market offers a number of strategic growth opportunities in key applications such as pharmaceuticals, medical devices, and patient care. The following are five major growth opportunities for the market.

• Pharmaceutical Innovation: There is great room for expansion in the creation of new drugs for Essential Tremor. Targeted therapies, designed to treat the root causes of tremor, will fuel market expansion. Furthermore, ongoing optimization of current medications to minimize side effects and maximize efficacy offer pharmaceutical firms the ability to improve their products in the ET market.
• Non-Invasive Therapies: Increased need for non-invasive treatments, including focused ultrasound and transcranial magnetic stimulation (TMS), creates a great opportunity for businesses to innovate and offer more treatment possibilities for Essential Tremor. These treatments are increasing in popularity as they can provide relief from tremors without resorting to invasive surgery, offering patients an appealing alternative with fewer risks.
• Telemedicine and Remote Monitoring: The infusion of telemedicine and remote monitoring technology into treatment of Essential Tremor presents one of the strongest opportunities for growth. These platforms give patients symptom management on a daily basis, allowing healthcare practitioners to adjust care in real-time. Telemedicine adoption across healthcare markets is also extremely valuable within underserved populations, enhancing accessibility of care to those who could otherwise have no care at all.
• Patient Education and Awareness Programs: Greater emphasis on patient education and awareness offers a market growth opportunity. As individuals become increasingly informed about Essential Tremor, they are more apt to seek early treatment and engage in treatment alternatives. Businesses can take advantage of this trend by funding educational efforts, developing tools for patients and physicians, and encouraging early diagnosis.
• Enhanced Access to Advanced Treatments: Increased availability of advanced therapy like DBS and focused ultrasound therapy is an opportunity for growth in the market for Essential Tremor. With improving healthcare systems in developing nations, these therapies will become more available to more people, fueling international market growth.

The essential tremor market holds huge growth opportunities in a number of key sectors, such as pharmaceutical innovation, non-invasive treatments, telemedicine, and patient education. With these opportunities being pursued and built upon, the market is projected to increase, enhancing the quality of treatment and access to treatment for patients suffering from Essential Tremor across the globe.

Essential Tremor Market Driver and Challenges

The essential tremor market is influenced by several drivers and challenges, such as technological innovations, economic factors, and regulatory factors. Knowing these factors is important in order to navigate the changing environment of the market. The following are five drivers and three challenges that are shaping the market.

The factors responsible for driving the essential tremor market include:

1. Increasing Incidence of Essential Tremor: With an aging global population, the prevalence of Essential Tremor is growing, fueling demand for treatments that work. Increasing numbers are looking for diagnosis and treatment, and healthcare systems are enlarging to accommodate. Growing incidence is a primary market driver.

2. Treatment Advances: Improvements in the availability of technological advances such as new drugs, deep brain stimulation (DBS), and other non-invasive treatments such as focused ultrasound are fueling the growth of the market. They provide better treatment outcomes for patients and are gaining wider acceptance

3. Increasing Awareness and Diagnosis: Growing awareness of Essential Tremor is resulting in earlier diagnosis and improved patient outcomes. With continuing awareness campaigns, more individuals are coming forward for treatment at an earlier stage, fueling market growth.

4. Enhanced Access to Healthcare: The development of healthcare infrastructure, especially in emerging countries, is enhancing access to treatment for Essential Tremor. As healthcare becomes more accessible, more patients are being diagnosed and treated, which is fueling market growth.

5. Patient-Centered Care: Patient-centered care is on the rise, with tailored treatment plans based on individual needs. It is increasing patient outcomes and adherence to treatment, which is augmenting market growth.

Challenges in the essential tremor market are:

1. High Cost of Treatment: New treatments for Essential Tremor, like DBS and focused ultrasound, are costly, restricting their availability in some areas. The cost of treatment is a major obstacle for most patients, especially in the developing world.

2. Limited Awareness in Certain Areas: Although awareness of Essential Tremor is increasing, certain areas remain unaware of the condition. This leads to delayed diagnosis and treatment, which can have adverse effects on patient outcomes.

3. Regulatory Barriers: Regulatory barriers can slow down the approval and availability of new therapies. Stringent regulatory procedures, particularly in developing markets, can hinder market growth and restrict the availability of innovative treatments.

The essential tremor market is fueled by growing incidence of the condition, increasing treatment options, and rising patient awareness. Nonetheless, high treatment costs, poor awareness in certain geographies, and regulatory issues are major restraints. Insight into these drivers and challenges is critical to traversing the shifting landscape of the market and driving further growth.

List of Essential Tremor Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies essential tremor companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the essential tremor companies profiled in this report include-

• InSightec's
• Merz Pharma
• Neurocrine Biosciences
• Sage Therapeutics

Essential Tremor Market by Segment

The study includes a forecast for the global essential tremor market by indication, end use, and region.

Essential Tremor Market by Indication [Value from 2019 to 2031]:

• Head
• Trunk
• Upper Extremity
• Lower Extremity

Essential Tremor Market by End Use [Value from 2019 to 2031]:

• Hospitals
• Ambulatory Surgical Center
• Diagnostic & Specialty Clinics

Essential Tremor Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Essential Tremor Market

The essential tremor market has seen some remarkable developments over the past few years, especially in terms of treatment avenues and access to healthcare. Essential Tremor (ET) is a very prevalent movement disorder, striking millions across the globe, and research and advancements undertaken in recent times have dramatically changed patient care for the better. Advances in pharmaceuticals, surgical procedures, and medical devices have made a huge difference in the management of this disorder. With a growing aging population and greater awareness, the demand for effective treatments is rising. In this context, we explore the recent developments in the essential tremor market across the United States, China, Germany, India, and Japan.

• United States: The essential tremor market in the United States is experiencing notable growth due to the increasing prevalence of the disorder and the expanding range of available treatments. Pharmaceutical advances, such as the approval of new drugs such as anaplastic thyroid cancer (ATC) inhibitors, have allowed for improved symptom control. Furthermore, advances in deep brain stimulation (DBS) and other surgical treatments have greatly enhanced outcomes for those with extreme tremor. The U.S. marketplace also has a well-established medical system in place, providing access to such advancements. Yet, there are challenges such as high treatment prices and continued research into more individualized treatments.
• China: In China, the market for Essential Tremor is growing as the population of the country ages, causing an increase in the incidence of neurological conditions like ET. The government's increasing emphasis on healthcare reform has enhanced access to diagnosis and treatment, especially in urban centers. Pharmaceutical interventions and DBS operations have become popular, but rural regions still lack access to these interventions. China's market for pharmaceuticals is also becoming increasingly competitive with the increased popularity of generic alternatives, which create affordable solutions for ET patients. There is more that can be done, however, despite this advancement, in the way of more inclusive healthcare policy to make treatments more accessible to the masses.
• Germany: Germany boasts one of the world's most advanced healthcare systems, and this is evident in how Essential Tremor is treated. Developments in pharmaceuticals and medical devices have enhanced the patient's quality of life for those afflicted with ET. Most significant among these advances has been the application of botulinum toxin injections and further development of DBS procedures. Germany's medical infrastructure provides patients with access to state-of-the-art technology and treatments. Still, some of the high prices of treatments and lengthy wait times for specialist visits in some regions continue to pose challenges. The market also is changing with heightened patient awareness and new clinical trials in process.
• India: India is witnessing greater awareness and accessibility of Essential Tremor, encouraged by a mounting population of the elderly as well as better healthcare access. Generic forms of largely prescribed drugs became available, helping ET treatment prices become more budget-friendly. Even so, access to sophisticated interventions such as DBS remains sparse in the entire country, but especially so outside major urban agglomerations in rural settings. There is also increasing demand for alternate forms of therapy, including physical therapy and herbal remedies, although these are still not conventional in ET treatment. India stands to witness further development in the ET market due to enhanced access to healthcare as well as publicity drives.
• Japan: There is a well-established health system in Japan that affords good access to diagnosis and treatment of Essential Tremor. Over the past few years, there has been a trend towards minimally invasive therapies like focused ultrasound therapy and newer DBS methods, which have helped improve outcomes. The increasing incidence of ET in the aging Japanese population has also fueled demand for treatment. Japan is also witnessing the introduction of newer pharmacological treatments for tremor control. Nevertheless, Japan is an important country in the global market of Essential Tremor. There are, however, difficulties to ensure equal treatment access throughout the country, particularly in rural locations.

Features of the Global Essential Tremor Market

Market Size Estimates: Essential tremor market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Essential tremor market size by indication, end use, and region in terms of value ($B).

Regional Analysis: Essential tremor market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different indication, end use, and regions for the essential tremor market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the essential tremor market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the essential tremor market by indication (head, trunk, upper extremity, and lower extremity), end use (hospitals, ambulatory surgical center, and diagnostic & specialty clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Essential Tremor Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Essential Tremor Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Essential Tremor Market by Indication
  • 3.3.1: Head
  • 3.3.2: Trunk
  • 3.3.3: Upper Extremity
  • 3.3.4: Lower Extremity
• 3.4: Global Essential Tremor Market by End Use
  • 3.4.1: Hospitals
  • 3.4.2: Ambulatory Surgical Center
  • 3.4.3: Diagnostic & Specialty Clinics

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Essential Tremor Market by Region
• 4.2: North American Essential Tremor Market
  • 4.2.1: North American Market by Indication: Head, Trunk, Upper Extremity, and Lower Extremity
  • 4.2.2: North American Market by End Use: Hospitals, Ambulatory Surgical Center, and Diagnostic & Specialty Clinics
• 4.3: European Essential Tremor Market
  • 4.3.1: European Market by Indication: Head, Trunk, Upper Extremity, and Lower Extremity
  • 4.3.2: European Market by End Use: Hospitals, Ambulatory Surgical Center, and Diagnostic & Specialty Clinics
• 4.4: APAC Essential Tremor Market
  • 4.4.1: APAC Market by Indication: Head, Trunk, Upper Extremity, and Lower Extremity
  • 4.4.2: APAC Market by End Use: Hospitals, Ambulatory Surgical Center, and Diagnostic & Specialty Clinics
• 4.5: ROW Essential Tremor Market
  • 4.5.1: ROW Market by Indication: Head, Trunk, Upper Extremity, and Lower Extremity
  • 4.5.2: ROW Market by End Use: Hospitals, Ambulatory Surgical Center, and Diagnostic & Specialty Clinics

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Essential Tremor Market by Indication
  • 6.1.2: Growth Opportunities for the Global Essential Tremor Market by End Use
  • 6.1.3: Growth Opportunities for the Global Essential Tremor Market by Region
• 6.2: Emerging Trends in the Global Essential Tremor Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Essential Tremor Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Essential Tremor Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: InSightec's
• 7.2: Merz Pharma
• 7.3: Neurocrine Biosciences
• 7.4: Sage Therapeutics